Cambridge Polymer Group Unveils Restructure to Accelerate Client Innovation through Material Science
Cambridge Polymer Group (CPG) announced a new leadership structure to better support clients in developing innovative products. CPG is creating a new five-person senior management team with deep materials science expertise, which will allow for closer collaboration with clients on complex projects. Dr. Gavin Braithwaite will be the new CEO and Dr. Stephen Spiegelberg will move to the new role of Chief Scientific Officer (CSO).
Woburn, MA, June 23, 2024 --(PR.com)-- Cambridge Polymer Group, Inc. (CPG), a leading contract research laboratory specializing in materials and their commercial applications, announced today a new operating model to meet demand for customized material optimization across the product lifecycle.
Addressing the Evolving Materials Landscape
Increasingly, manufacturers and product designers across all industries are using new materials in novel applications and pushing existing materials into new uses that stretch their performance to the limit. These materials do not always behave as expected, and conventional material specification sheets and standard testing methods are no longer enough.
Today's successful products can only be obtained through a multi-disciplinary approach, with an emphasis on safety. Developers need deep expertise in materials across industries, along with a thorough understanding of polymer science. This includes the impact of additives, manufacturability (encompassing cleaning and sterilization), biocompatibility, and the intended use of the device or product.
Enhanced Client Collaboration through SME Leadership
To address this growing need for materials expertise, Cambridge Polymer Group is implementing a new five-position management structure. This structure empowers senior Subject Matter Experts to remain at the forefront of client collaboration – a cornerstone of CPG’s successful partnerships. This strategic shift ensures dedicated resources for complex projects, delivering the hands-on materials support clients increasingly require.
Vice President of Research, Dr. Gavin Braithwaite, will step into the newly created position of Chief Executive Officer.
“By staffing our newly designed senior management structure with seasoned scientists, we can ensure the continued delivery of high-quality science to our clients, while placing a stronger emphasis on product development and challenging testing projects,” said Braithwaite. “I am excited to grow the development aspect of our work and build a deeper relationship with our clients, helping them decrease risk, expand into new markets, and increase profitability.”
After 27 years as Cambridge Polymer Group’s President, Dr. Stephen Spiegelberg is moving into the new role of Chief Scientific Officer (CSO). This transition will enable Dr. Spiegelberg to spend more time collaborating with clients and working on large-scale projects in his subject matter expertise, such as biocompatibility, root cause analysis, product development, and medical device cleaning.
“I am personally looking forward to having more scientific interactions with our clients, spending more time on ASTM and AAMI standards development, and studying industry trends to help assist in product development,” said Spiegelberg.
Jaimee Robertson will oversee research operations in the newly created role of Director of Consulting Services, working with CEO Gavin Braithwaite and CSO Stephen Spiegelberg to develop and implement CPG’s research strategy and assist clients in their development projects and root cause analysis work.
Norma Turner will manage lab operations and testing services as Director of Analytical Services, ensuring CPG’s full-service laboratory provides essential support for R&D and consulting projects, as well as value-add to routine analytical testing clients. Norma will be leveraging her extensive experience in ASTM and ISO standards testing to help with both routine and non-routine testing, including residue analysis and extractables and leachables testing.
Dr. Rebecca Bader, Associate Director of Chromatography, will oversee the direction of this critical department and lead CPG’s biocompatibility and risk assessment group. Bader’s material science and analytical chemistry expertise combined with her biocompatibility experience will help clients navigate the challenging regulatory landscape.
Benefits for Clients
· Deeper Collaboration with Material Experts: Clients continue to benefit from close collaboration with CPG's SMEs.
· Enhanced Support for Complex Projects: The new structure ensures dedicated resources for even the most demanding R&D initiatives.
· Future-Proofed Innovation: CPG is positioned to deliver the advanced materials expertise needed to bring groundbreaking products to market.
About Cambridge Polymer Group
Cambridge Polymer Group, (Inc.) is a contract research laboratory with over 28 years providing consulting, material/product development, and analytical testing services with a focus on polymeric materials. Collectively our key personnel represent more than 100 years of experience in biomedical materials, medical devices, polymer science and related disciplines. We solve the world’s toughest material problems, making safer, more reliable, and more cost-effective medical devices, energy, consumer, and industrial products. We are actively working on projects that range from orthopedic and ophthalmic materials to vibration dampers and EV (Electric Vehicle) materials in the automotive industry. In addition to advancing clients’ IP, CPG has its own internal R&D department, responsible for over 85 patents, including a Vitamin E formulation which has led to improved outcomes in knee and hip replacements for patients worldwide.
CPG is an ISO 9001:2015 certified, ISO 17025:2005 accredited, DEA licensed, FDA registered, and GLP compliant laboratory.
If you would like more information about this topic, please call Catherine Cerasuolo at 617-629-4400, or email Catherine.Cerasuolo@campoly.com.
Addressing the Evolving Materials Landscape
Increasingly, manufacturers and product designers across all industries are using new materials in novel applications and pushing existing materials into new uses that stretch their performance to the limit. These materials do not always behave as expected, and conventional material specification sheets and standard testing methods are no longer enough.
Today's successful products can only be obtained through a multi-disciplinary approach, with an emphasis on safety. Developers need deep expertise in materials across industries, along with a thorough understanding of polymer science. This includes the impact of additives, manufacturability (encompassing cleaning and sterilization), biocompatibility, and the intended use of the device or product.
Enhanced Client Collaboration through SME Leadership
To address this growing need for materials expertise, Cambridge Polymer Group is implementing a new five-position management structure. This structure empowers senior Subject Matter Experts to remain at the forefront of client collaboration – a cornerstone of CPG’s successful partnerships. This strategic shift ensures dedicated resources for complex projects, delivering the hands-on materials support clients increasingly require.
Vice President of Research, Dr. Gavin Braithwaite, will step into the newly created position of Chief Executive Officer.
“By staffing our newly designed senior management structure with seasoned scientists, we can ensure the continued delivery of high-quality science to our clients, while placing a stronger emphasis on product development and challenging testing projects,” said Braithwaite. “I am excited to grow the development aspect of our work and build a deeper relationship with our clients, helping them decrease risk, expand into new markets, and increase profitability.”
After 27 years as Cambridge Polymer Group’s President, Dr. Stephen Spiegelberg is moving into the new role of Chief Scientific Officer (CSO). This transition will enable Dr. Spiegelberg to spend more time collaborating with clients and working on large-scale projects in his subject matter expertise, such as biocompatibility, root cause analysis, product development, and medical device cleaning.
“I am personally looking forward to having more scientific interactions with our clients, spending more time on ASTM and AAMI standards development, and studying industry trends to help assist in product development,” said Spiegelberg.
Jaimee Robertson will oversee research operations in the newly created role of Director of Consulting Services, working with CEO Gavin Braithwaite and CSO Stephen Spiegelberg to develop and implement CPG’s research strategy and assist clients in their development projects and root cause analysis work.
Norma Turner will manage lab operations and testing services as Director of Analytical Services, ensuring CPG’s full-service laboratory provides essential support for R&D and consulting projects, as well as value-add to routine analytical testing clients. Norma will be leveraging her extensive experience in ASTM and ISO standards testing to help with both routine and non-routine testing, including residue analysis and extractables and leachables testing.
Dr. Rebecca Bader, Associate Director of Chromatography, will oversee the direction of this critical department and lead CPG’s biocompatibility and risk assessment group. Bader’s material science and analytical chemistry expertise combined with her biocompatibility experience will help clients navigate the challenging regulatory landscape.
Benefits for Clients
· Deeper Collaboration with Material Experts: Clients continue to benefit from close collaboration with CPG's SMEs.
· Enhanced Support for Complex Projects: The new structure ensures dedicated resources for even the most demanding R&D initiatives.
· Future-Proofed Innovation: CPG is positioned to deliver the advanced materials expertise needed to bring groundbreaking products to market.
About Cambridge Polymer Group
Cambridge Polymer Group, (Inc.) is a contract research laboratory with over 28 years providing consulting, material/product development, and analytical testing services with a focus on polymeric materials. Collectively our key personnel represent more than 100 years of experience in biomedical materials, medical devices, polymer science and related disciplines. We solve the world’s toughest material problems, making safer, more reliable, and more cost-effective medical devices, energy, consumer, and industrial products. We are actively working on projects that range from orthopedic and ophthalmic materials to vibration dampers and EV (Electric Vehicle) materials in the automotive industry. In addition to advancing clients’ IP, CPG has its own internal R&D department, responsible for over 85 patents, including a Vitamin E formulation which has led to improved outcomes in knee and hip replacements for patients worldwide.
CPG is an ISO 9001:2015 certified, ISO 17025:2005 accredited, DEA licensed, FDA registered, and GLP compliant laboratory.
If you would like more information about this topic, please call Catherine Cerasuolo at 617-629-4400, or email Catherine.Cerasuolo@campoly.com.
Contact
Cambridge Polymer Group
Catherine Cerasuolo
617-629-4400
www.campoly.com
Catherine Cerasuolo
617-629-4400
www.campoly.com
Contact
Categories